Company Profile

Alleviant Medical Inc
Profile last edited on: 2/13/2023      CAGE: 7VVS3      UEI: HJG7YF67LBA3

Business Identifier: Therapies for congestive heart failure.
Year Founded
2017
First Award
2018
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

7801 North Lamar Boulevard Suite D-106
Austin, TX 78752
   (417) 438-2980
   info@alleviantmedical.com
   www.alleviantmedical.com
Location: Single
Congr. District: 37
County: Harris

Public Profile

An Alumni of the JLab facility in Houston, TX, Alleviant Medical is a medical device company organized around therapies for congestive heart failure involving a novel, minimally-invasive device. Characteristically, heart faiure patients have a weakened heart muscle not able pump to blood throughout the body. Typically, pressure builds in the left atrium, leading to fluid accumulation in the lungs and severe shortness of breath. In major part, existing medications are ineffective at relieving symptoms and hospital admissions is often necessary: a substantial clinical and economic burden with limited treatment options. With significant economic and clinical postive impact, Alleviant Medical's device - transcatheter technology - is designed to relieve pressure the left atrium using an inter arterial shunt between the left and right atrium. The shunt is intended to allow pressure to offload from the left atrium into the lower pressure right atrium with consequent significant economic and clinical postive impact.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NIH $2,229,299
Project Title: Transcatheter Device for Congestive Heart Failure Treatment Through Left Atrial Decompression

Key People / Management

  Alec (Christopher) Arevalos -- Co-Founder and CEO

  Jacob Kriegel -- Co-Founder and CEO

  Adam Berman -- President & CEO

  Albertien Greijdanus -- Co-Founder and VP Finance, Admin & HR

  Thomas Diffley Pate

  Avni Patel

Company News

There are no news available.